AtriCure (ATRC) Tops Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to AtriCure (ATRC) Tops Q1 EPS by 2c

AtriCure Reports First Quarter 2016 Financial Results

April 28, 2016 4:08 PM EDT

Revenue of $35.9 million up 20.3% as reported, 20.4% constant currency U.S. sales of $28.3 million up 23.3% International sales of $7.7 million up 10.1% as reported, 10.9% constant currency

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced first quarter 2016 financial results.

We are pleased to report first quarter results which reflect solid operational and commercial execution. Performance in the quarter was again marked by continued growth from U.S.... More